Daelman L, Sedel F, Tourbah A
Department of Neurology, CHU de Reims, 45, rue Cognacq-Jay, 51100 Reims, France; URCA, UFR Médecine, 45, rue Cognacq-Jay, 51100 Reims, France.
Department of Neurology, Neurometabolic Unit and Reference Center for Lysosomal Diseases, Salpêtrière Hospital, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France; Groupe de recherche en neurométabolisme (GRC13), Université Pierre-et-Marie-Curie, 4, place Jussieu, 75005 Paris, France.
Rev Neurol (Paris). 2014 Apr;170(4):280-7. doi: 10.1016/j.neurol.2013.09.012. Epub 2014 Apr 13.
Neuropsychiatric signs and MRI abnormalities can occur in patients with phenylketonuria in adulthood. We describe clinical and radiological features of phenylketonuric patients and we discuss the advantage of continuing diet in adulthood.
We report late onset neuropsychiatric symptoms of four phenylketonuric patients (33-45years) diagnosed in infancy and report the case of a patient (33years) diagnosed with phenylketonuria because of late onset neurological signs. We describe clinical and radiological features of these 5 patients, and their evolution under diet and propose a review of the literature.
The main neurological abnormalities in phenylketonuric patients diagnosed in infancy are: brisk reflexes, spastic paraparesis, psychiatric signs that appear 10.5years after the diet arrest. A leukoencephalopathy was present in 93% of cases and 91.7% improve clinically after poor phenylalanine diet reintroduction. In 4 patients, neurological abnormalities (spastic paraparesis, dementia, Parkinsonism) led to the late diagnosis. Two of them had a leukoencephalopathy on brain MRI. Patients had high levels of phenylalanine (above 1500μmol/L) when neuropsychiatric signs occurred. Improvement after diet suggests that hyperphenylalaninemia has a direct toxic effect on the brain.
DISCUSSION/CONCLUSION: The long-term follow-up of phenylketonuric patients is mandatory to depict and treat neurological complications in time. Diet reintroduction is efficacious in most cases.
成年苯丙酮尿症患者可出现神经精神症状和磁共振成像(MRI)异常。我们描述了苯丙酮尿症患者的临床和影像学特征,并讨论了成年后持续饮食治疗的益处。
我们报告了4例婴儿期诊断的苯丙酮尿症患者(33 - 45岁)的迟发性神经精神症状,并报告了1例因迟发性神经体征而诊断为苯丙酮尿症的患者(33岁)。我们描述了这5例患者的临床和影像学特征,以及他们在饮食治疗下的病情演变,并对文献进行了综述。
婴儿期诊断的苯丙酮尿症患者的主要神经异常表现为:反射亢进、痉挛性截瘫、在饮食停止后10.5年出现的精神症状。93%的病例存在白质脑病,在重新引入低苯丙氨酸饮食后,91.7%的患者临床症状改善。4例患者因神经异常(痉挛性截瘫、痴呆、帕金森综合征)导致诊断延迟。其中2例脑部MRI显示有白质脑病。神经精神症状出现时,患者苯丙氨酸水平较高(高于1500μmol/L)。饮食治疗后症状改善表明高苯丙氨酸血症对大脑有直接毒性作用。
讨论/结论:对苯丙酮尿症患者进行长期随访对于及时描述和治疗神经并发症至关重要。在大多数情况下,重新引入饮食治疗是有效的。